Physician profile
Michael Ciccone
NPI 1649294034
$3,456.83
in general payments reported to CMS, 2019-2025
25 companies · $226 in 2025
The $226 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $745 · 2020: $220 · 2021: $1,522 · 2022: $165 · 2023: $275 · 2024: $303 · 2025: $226.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $805.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $804.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $1,232.73 | 2019-2025 | |
| Astellas Pharma US INC | $450.69 | 2019-2022 | |
| Procept Biorobotics Corporation | $268.85 | 2021-2025 | |
| Boston Scientific Corporation | $183.99 | 2020-2025 | General - Erectile Dysfunction |
| Axonics, INC. | $146.10 | 2023 | Bulkamid, Axonics |
| Coloplast Corp | $144.11 | 2024 | |
| Kerecis Limited | $136.60 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Pfizer INC. | $136.39 | 2019-2020 | |
| Janssen Biotech, INC. | $113.44 | 2019-2025 | Erleada |
| Chiesi USA, INC. | $105.16 | 2022 | |
| Koelis INC. | $98.86 | 2021 | |
| Amgen INC. | $96.26 | 2019-2020 | |
| Abbvie INC. | $57.41 | 2019 | |
| Allergan, INC. | $56.84 | 2019-2021 | |
| Endo Pharmaceuticals INC. | $39.90 | 2019-2020 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tolmar Pharmaceuticals, INC. | $39.55 | 2019-2020 | |
| Ferring Pharmaceuticals INC. | $38.41 | 2019 | |
| Medtronic USA, INC. | $27.01 | 2019 | |
| Davol INC. | $17.75 | 2019 | |
| Medtronic, INC. | $16.10 | 2021 | |
| Dendreon Pharmaceuticals LLC | $14.78 | 2019 | |
| Blue Earth Diagnostics | $13.21 | 2019 | |
| Royal Biologics, INC. | $11.53 | 2020 | |
| Aytu Biopharma, INC. | $11.16 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Ciccone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.